To the relief of patients diagnosed with hepatitis C, the U.S. Food and Drug Administration approved two new treatments late last year, and a few more are on the way.
Now scientists are solving another side of the disease’s problem: identifying the millions more who have the virus but don’t know it — and unwittingly pass it on. A report in the ACS journal Analytical Chemistry describes a novel, scrapbook-inspired test that does just that.
Xuan Mu, Zhi Zheng and colleagues point out that the hepatitis C virus (HCV), a blood-borne pathogen that can cause liver cirrhosis, cancer and even death, kills more people in the U.S. than HIV. It also infects an estimated 150 million people around the world. Although diagnostic tests exist, they require an initial screening and then a costly second test for confirmation. The extra office visits, money and time required for a definitive diagnosis means a lot of people simply can’t or won’t follow up. To make diagnosis more accessible, the researchers took advantage of the recent development of new, inexpensive paper-based medical technologies and applied it to HCV screening.
Taking a page from the popular scrapbooking pastime, the scientists used a flower-shaped metal paper cutter to punch out shapes from special paper for their diagnostic test. The method solves the problem of patterning the paper, made of nitrocellulose — a highly flammable substance — without using heat. They add antigens, antibodies and other chemicals to the paper to test patient samples. With one flower-shaped paper, they can conduct both HCV tests on a sample simultaneously in just minutes, instead of hours.
The Latest on: Paper-based diagnostics
[google_news title=”” keyword=”Paper-based diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Paper-based diagnostics
- New Google medical AI “Med-Gemini” is surprising doctorson May 4, 2024 at 5:03 am
Google has released a new medical AI aptly named Med-Gemini which builds on the companies powerful Gemini large language model ...
- Babson Diagnostics Partners with Cynergy Wellness, Inc.on May 3, 2024 at 5:37 am
Babson Diagnostics, a science-first health care technology company, today announced a partnership with Cynergy Wellness, Inc., a privately-owned provider of nationwide physician services for workplace ...
- Researchers unveil single-shot and complete polarization imaging system using metasurfaceson May 2, 2024 at 8:03 am
Think of all the information we get based on how an object interacts with wavelengths of light—aka color. Color can tell us if food is safe to eat or if a piece of metal is hot. Color is an important ...
- Google’s Med-Gemini Model Achieves 91.1% Accuracy in Medical Diagnosticson May 2, 2024 at 5:48 am
Google and DeepMind's latest model excels in multimodal medical dialogues with diagnostic precision. The model has surpassed existing benchmarks.
- Can At-Home Vision Tests Detect Active Neovascular AMD?on May 1, 2024 at 9:00 pm
Opens in a new tab or window Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The ...
- Quest Finds its Path to AI in Cancer Diagnostics Through M&Aon May 1, 2024 at 10:25 am
Quest Diagnostics has found its path to artificial intelligence in cancer diagnosis through M&A. The Secaucus NJ-based company said it was acquiring select assets of PathAI Diagnostics, the business ...
- Quest Diagnostics carves out PathAI's digital pathology lab, plots AI ramp-upon May 1, 2024 at 7:30 am
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multi-layered deal with PathAI—acquiring some assets, licensing out others. | Quest ...
- Labcorp nets companion diagnostic approval for Pfizer's hemophilia B gene therapy Beqvezon April 29, 2024 at 10:56 am
The FDA approved its first gene therapy companion diagnostic test last June, developed through a collaboration between ARUP Laboatories and BioMarin, maker of the hemophilia A treatment Roctavian ...
- AI tool may help detect cancer in a few minutes with a drop of bloodon April 29, 2024 at 7:57 am
An AI-powered tool may be able to detect pancreatic, gastric, or colorectal cancer with a sensitivity of 82–100% and takes just a few minutes, a new study indicates.
- How AI-Driven Diagnostics Can Save Lives When Humans Can’ton April 28, 2024 at 8:48 pm
AI offers promise in improving diagnostics, detecting conditions faster and more accurately than humans. It can alleviate staff workload and improve health outcomes ...
via Bing News